CEO selling ~$6.3M (~0.35% of position) is a moderate but notable insider divestment at 90% consensus bullish. Watch for Form 4 filings confirming execution—repeated large sales would carry more weight. For now, treat as a signal to monitor insider sentiment, not an emergency exit.
Price Chart
Executive Summary
CEO Sean Brynjelsen filed a Form 144 to sell 100,000 shares of Eton Pharmaceuticals common stock, valued at approximately $6.34 million based on the filing date. This represents about 3.5% of his reported holdings, signaling a notable insider liquidity event at a $1.8B market cap company with strong 90% analyst bullish consensus.
Key Facts
- Filer: Sean Brynjelsen, CEO and Director, a 10% stockholder of Eton Pharmaceuticals
- Number of shares planned for sale: 100,000 shares of common stock
- Approximate market value of sale: $6,343,000 based on filing date close
- Shares held by filing person: 28,583,135 (the sale represents ~0.35% of total holdings)
- Shares acquired on 05/17/2017 as founder shares from the issuer
- Broker: Raymond James and Associates Inc.
- Date of notice: 08/19/2026, with intention to sell on or around the same date on Nasdaq
- Market cap: $1.8B; analyst consensus: 90% bullish (2 Strong Buy, 7 Buy)
Financial Impact
CEO proposes to sell ~$6.34M worth of shares, equal to ~0.35% of his total 28.6M share position
Risk Factors
- CEO may be diversifying, reducing alignment with shareholders
- Sale could precede negative news or underperformance not yet public
- Form 144 is intent only; sale may not execute—monitor subsequent Form 4 confirmations
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001974078-26-000315 |
| Document: 0001974078-26-000315-index.html | 0001974078-26-000315 |
| Document: 0001974078-26-000315.txt | 0001974078-26-000315 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 14, 2026 13d ago | 8-K | $52.88 | awaiting T+60 | — | $51.16 (−3.25%) |
Oct 6, 2026 21d ago | 144 | $54.88 | awaiting T+60 | — | $51.16 (−6.78%) |
Sep 28, 2026 29d ago | 8-K | $59.18 | awaiting T+60 | — | $51.16 (−13.55%) |
Aug 31, 2026 8w ago | Insider Cluster | $60.43 | awaiting T+60 | — | $51.16 (−15.34%) |
Aug 28, 2026 8w ago | Insider Cluster | $60.44 | awaiting T+60 | — | $51.16 (−15.35%) |
Aug 24, 2026 9w ago | Insider Cluster | $63.05 | awaiting T+60 | — | $51.16 (+18.86%) |
Aug 19, 2026 9w ago | 144 | $61.48 | awaiting T+60 | — | $51.16 (+16.79%) |
Aug 5, 2026 11w ago | 8-K | $45.97 | awaiting T+60 | — | $51.16 (+11.29%) |
Aug 5, 2026 11w ago | Press Release | $45.97 | awaiting T+60 | — | $51.16 (+11.29%) |
Aug 4, 2026 12w ago | 8-K | $45.83 | awaiting T+60 | — | $51.16 (+11.63%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers